Rare Brain Complication After Stem Cell Transplant Reported in New England Journal

The New England Journal of Medicine posted details of a newly published correspondence piece examining a rare but serious brain condition — measles inclusion-body encephalitis (MIBE), a form of brain inflammation caused by the measles virus — appearing in a patient after an allogeneic (donor) stem cell transplant. The case adds to a small body of medical literature on how the measles virus can re-emerge in people whose immune systems have been severely weakened by transplant treatment.

MIBE is distinct from the more commonly discussed acute measles encephalitis. It can develop weeks or months after measles infection in people with compromised immune systems — including those who have undergone stem cell transplantation — and is considered extremely rare. The New England Journal of Medicine is a peer-reviewed medical journal widely regarded as one of the most authoritative sources in clinical medicine.

The journal did not, in this post, provide full case details beyond the correspondence title. No specific patient location, age, or outcome figures were included in the tweet.

For Kent residents who have had, or are awaiting, a stem cell transplant, any new neurological symptoms — such as confusion, seizures, or changes in behaviour — should be discussed with your transplant team or GP without delay. Do not wait for a routine appointment.

Key information

• If you have concerns about symptoms after a stem cell transplant, contact your specialist team or call NHS 111
• For medical emergencies, call 999
• The measles, mumps and rubella (MMR) vaccine is available free on the NHS — speak to your GP about eligibility, above all if you are a carer or household contact of an immunocompromised person
• The full correspondence is published in the *New England Journal of Medicine*